Black Bird Biotech, Inc. engages in the manufacture and sale of cannabidiol products through its subsidiary, Black Bird Potentials, Inc. Its products include MiteXstream, Grizzly Creek Naturals, and Black Bird American Hemp. The company is headquartered in Argyle, Texas and currently employs 4 full-time employees. The company went IPO on 2007-12-10. The firm also manufactures and sells, under its Grizzly Creek Naturals brand name, cannabidiol (CBD) products, including CBD Oils, gummies and pet treats, as well as CBD-infused personal care products. The firm's subsidiaries include Black Bird Potentials Inc. (BB Potentials), Big Sky American Dist., LLC (Big Sky American) and Black Bird Hemp Manager, LLC. Big Sky American Dist., LLC distributes its Grizzly Creek Naturals products, as well as an array of other consumer retail products, in Western Montana.
Black Bird Biotech Incの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Black Bird Biotech Incの収益はセグメントまたは地域別にどのように分けられていますか?
Black Bird Biotech Inc の最大収益セグメントは Subscriptions and Other Revenue で、最新の利益発表における収益は 103,336 です。地域別に見ると、United States が Black Bird Biotech Inc の主要市場であり、収益は 181,476 です。